CGBD vs DRUG

Comparison between Carlyle Secured Lending Inc (CGBD, Company) and Bright Minds Biosciences Inc (DRUG, Company).

CGBD is from the Financial Services sector, while DRUG is from the Healthcare sector.

5-Year PerformanceDRUG has outperformed CGBD, delivering a return of +27.0% compared to +6.4%

CGBD vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CGBD(COMPANY)	DRUG(COMPANY)
Market Cap	$725M	$724M
Max Drawdown	78.14%	97.68%
Sharpe Ratio	-0.93	1.67
5Y Beta	0.62	-0.76
Industry	Asset Management	Biotechnology
P/E Ratio	14.52	-30.67
Forward P/E	7.58	N/A
PEG Ratio	3.54	-0.08
Dividend Yield	15.30%	N/A
5Y Dividends CAGR	5.96%	N/A
5Y EPS CAGR	N/A	8.42%
Debt to Equity	123.55%	0.03%
Free Cash Flow Yield	-19.03%	-2.01%
P/S Ratio	2.71	N/A
P/B Ratio	0.65	3.49

Market Cap

Winner

CGBD

$725M

DRUG

$724M

Max Drawdown

Winner

CGBD

78.14%

DRUG

97.68%

Sharpe Ratio

CGBD

-0.93

Winner

DRUG

1.67

5Y Beta

CGBD

0.62

Winner

DRUG

-0.76

Industry

CGBD

Asset Management

DRUG

Biotechnology

P/E Ratio

CGBD

14.52

Winner

DRUG

-30.67

Forward P/E

CGBD

7.58

DRUG

N/A

PEG Ratio

CGBD

3.54

Winner

DRUG

-0.08

Dividend Yield

CGBD

15.30%

DRUG

N/A

5Y Dividends CAGR

CGBD

5.96%

DRUG

N/A

5Y EPS CAGR

CGBD

N/A

DRUG

8.42%

Debt to Equity

CGBD

123.55%

Winner

DRUG

0.03%

Free Cash Flow Yield

CGBD

-19.03%

Winner

DRUG

-2.01%

P/S Ratio

CGBD

2.71

DRUG

N/A

P/B Ratio

Winner

CGBD

0.65

DRUG

3.49

CGBD vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	CGBD	DRUG
1 month	-3.52%	+9.46%
3 months	-9.91%	-19.61%
6 months	-16.24%	-18.06%
1 year	-18.38%	+138.59%
5 years(CAGR)	+6.38%	+26.98%
10 years(CAGR)	+6.01%	N/A
Max(CAGR)	+6.01%	+19.96%

CGBD

-3.52%

Winner

DRUG

+9.46%

Winner

CGBD

-9.91%

DRUG

-19.61%

Winner

CGBD

-16.24%

DRUG

-18.06%

CGBD

-18.38%

Winner

DRUG

+138.59%

5Y(CAGR)

CGBD

+6.38%

Winner

DRUG

+26.98%

10Y(CAGR)

CGBD

+6.01%

DRUG

N/A

Max(CAGR)

CGBD

+6.01%

Winner

DRUG

+19.96%

CGBD vs DRUG - Annual Returns (2017 - 2026)

Returns include dividend reinvestment.

Year	CGBD	DRUG
2026	-14.57%	-14.58%
2025	-22.30%	+89.83%
2024	+33.98%	+1859.10%
2023	+15.85%	-63.33%
2022	+17.64%	-78.04%
2021	+49.86%	-41.30%
2020	-8.93%	N/A
2019	+17.77%	N/A
2018	-25.29%	N/A
2017	+18.03%	N/A

CGBD vs DRUG Drawdown Comparison

The maximum drawdown for CGBD was -71.12%, occurring on Mar 23, 2020. Recovery took 804 trading sessions.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current CGBD drawdown is -34.96%. The current DRUG drawdown is -25.73%.

Rank	CGBD	DRUG
#1	-71.12% Dec 29, 2017 - Mar 12, 2021	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	-35.08% Jan 31, 2025 - Mar 16, 2026	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	-18.93% Aug 12, 2022 - Nov 15, 2022	-38.35% Jan 7, 2026 - Jun 15, 2026
#4	-17.72% Apr 19, 2022 - Aug 11, 2022	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	-13.98% Feb 24, 2023 - Jul 7, 2023	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	-12.77% Jul 28, 2023 - Dec 13, 2023	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	-12.20% Jul 16, 2024 - Dec 11, 2024	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	-9.75% Oct 3, 2017 - Dec 27, 2017	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	-7.87% Apr 29, 2021 - Aug 4, 2021	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	-5.55% Jan 8, 2024 - Feb 27, 2024	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	-5.32% Aug 12, 2021 - Oct 19, 2021	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	-4.84% Nov 5, 2021 - Jan 4, 2022	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	-4.47% Jan 12, 2022 - Mar 2, 2022	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	-3.91% Mar 2, 2022 - Mar 17, 2022	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	-3.68% Jan 3, 2025 - Jan 16, 2025	-3.81% Sep 1, 2021 - Sep 17, 2021